The business grew, but first-quarter results missed estimates.
Pharmaceutical giant AbbVie Inc. (ABBV) shares came under pressure as the market closed on Friday, following the disappointing first quarter sales performance of the company's arthritis drug, Humira. The company forecast that Humira's sales could slow further in the face of heightened competition. Yahoo Finance's health reporter Anjalee Khemlani breaks down the details, providing insight into the rise of biosimilars in the market. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance. This post was written by Angel Smith
Arlington, Virginia--(Newsfile Corp. - April 26, 2024) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) ("edgeTI", "Edge Technologies", "Company"), the provider of edgeCore™, a leading real-time Digital Twins platform, announces that Ms. Fay Arjomandi has resigned from the board of directors of edgeTI effective April 25, 2024, to pursue other opportunities. edgeTI would like to thank Ms. Arjomandi for her contributions and wishes her all the best in her future endeavors.Subj
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|
Simbolo | Ultimo prezzo | Variazione | % variazione |
---|---|---|---|